Pluristem Therapeutics, Inc. News Headlines

PSTI 
$2.96
*  
0.01
0.34%
Get PSTI Alerts
*Delayed - data as of Sep. 18, 2014 14:34 ET  -  Find a broker to begin trading PSTI now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    PSTI Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Buy or Sell? Thursday's Losers: Pluristem (Nasdaq: PLSTM) and FirstMerit (Nasdaq: FMER)
9/13/2012 9:45:00 AM - David Sterman

Biotech: On The Way To Meeting Highly Ambitious Expectations
9/10/2012 11:41:00 AM - Seeking Alpha

Stem Cell Therapy: The Black And White Therapies Of The Space
9/10/2012 3:54:00 AM - Seeking Alpha

Orphan Status Sought for PSTI Drug - Analyst Blog
8/31/2012 5:32:48 PM - Zacks.com

Pluristem to Begin IC Phase II Trial - Analyst Blog
8/24/2012 6:30:01 PM - Zacks.com

Pluristem-BCRT Alliance Extended - Analyst Blog
8/22/2012 7:32:12 PM - Zacks.com

Pluristem Gets Green Light in India - Analyst Blog
8/20/2012 7:32:06 PM - Zacks.com

Pluristem Vs. Geron: An Insider's View Of The Stem Cell Story
12/19/2011 3:45:00 AM - Seeking Alpha

InVivo's Innovative Instigation In Spinal Cord Injury
11/11/2011 1:17:00 PM - Seeking Alpha

Biotechs Placing Bets On Cell Therapy Success
10/7/2011 10:50:00 AM - Seeking Alpha

6 Biotech Penny Stocks to Buy
6/24/2011 2:00:42 AM - Louis Navellier

Competition Between Aastrom Bio and Pluristem Heating Up
4/18/2011 12:27:00 PM - Seeking Alpha

Agencies Agree to Consider Consider Clinical Studies Proposal for Pluristem Pipeline
1/18/2011 8:27:00 PM - Seeking Alpha

Mesoblast/Cephalon Deal Highlights Potential Pluristem Therapeutics Value
1/5/2011 5:06:00 PM - Seeking Alpha

Six Reasons to Like Pluristem Therapeutics
10/13/2010 8:25:00 AM - Seeking Alpha

Stem Cell Competition Heating Up
8/25/2010 3:04:00 AM - Seeking Alpha

Biotech CROs Take Center Stage in Recent Deals
5/2/2010 5:22:00 AM - Seeking Alpha